EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.4.1.317 | 5-O-beta-D-mycaminosyltylonolide + dTDP-6-deoxy-alpha-D-allose |
- |
Streptomyces fradiae |
dTDP + demethyllactenocin |
demethyllactenocin i.e. [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-[[3,6-dideoxy-3-(dimethylamino)-D-glucopyranosyl]oxy]-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-beta-D-allopyranoside |
? |
2.4.1.317 | 5-O-beta-D-mycaminosyltylonolide + dTDP-6-deoxy-alpha-D-allose |
the enzyme participates in the biosynthetic pathway of the macrolide antibiotic tylosin |
Streptomyces fradiae |
dTDP + demethyllactenocin |
demethyllactenocin i.e. [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-[[3,6-dideoxy-3-(dimethylamino)-D-glucopyranosyl]oxy]-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-beta-D-allopyranoside |
? |
2.4.1.317 | 5-O-beta-D-mycaminosyltylonolide + dTDP-6-deoxy-alpha-D-allose |
- |
Streptomyces fradiae T59235 |
dTDP + demethyllactenocin |
demethyllactenocin i.e. [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-[[3,6-dideoxy-3-(dimethylamino)-D-glucopyranosyl]oxy]-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-beta-D-allopyranoside |
? |
2.4.1.317 | 5-O-beta-D-mycaminosyltylonolide + dTDP-6-deoxy-alpha-D-allose |
the enzyme participates in the biosynthetic pathway of the macrolide antibiotic tylosin |
Streptomyces fradiae T59235 |
dTDP + demethyllactenocin |
demethyllactenocin i.e. [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-[[3,6-dideoxy-3-(dimethylamino)-D-glucopyranosyl]oxy]-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-beta-D-allopyranoside |
? |